Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-016742
Filing Date
2013-03-13
Accepted
2013-03-13 18:11:42
Documents
1
Period of Report
2013-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd373662.html 4  
1 FORM 4 rrd373662.xml 4 11103
  Complete submission text file 0001181431-13-016742.txt   12623
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Kaldor Stephen W (Reporting) CIK: 0001507502 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34641 | Film No.: 13688520